Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $5.97 Million - $7.38 Million
-15,200 Reduced 49.03%
15,800 $7.41 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $11.1 Million - $12.2 Million
27,300 Added 737.84%
31,000 $13 Million
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $1.3 Million - $1.56 Million
-3,800 Reduced 50.67%
3,700 $1.51 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $282,978 - $316,719
-900 Reduced 10.71%
7,500 $2.64 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $594,783 - $678,510
2,100 Added 33.33%
8,400 $2.65 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $1.4 Million - $1.58 Million
4,900 Added 350.0%
6,300 $1.82 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $383,362 - $427,741
1,400 New
1,400 $405,000
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $9.59 Million - $12.9 Million
-57,500 Reduced 64.9%
31,100 $6.81 Million
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $10.2 Million - $11.4 Million
61,200 Added 223.36%
88,600 $15 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $2.81 Million - $3.26 Million
17,100 Added 166.02%
27,400 $5.03 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $1.69 Million - $2.01 Million
10,300 New
10,300 $1.9 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.